PATENT CLAIM ANALYSIS

Application Number: 16048665
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "211150"]

Abstract:
The invention relates to morpholine and 1,4-oxazepane amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.

Claim (Index 16):
A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein m=0, p=1, q=1 or; m=1, p=1, q=1 or; m=0, p=2, q=1 or; m=0, p=1, q=2. \u2003A is selected from the group consisting of H and C 1-6 -alkyl; R 1  and R 2  are independently selected from the group consisting of C 1-6 -alkyl and C 3-6 -cycloalkyl, or wherein IV and R 2  together form a 2- to 5-membered alkylene-bridge incorporating 0 to 2 heteroatoms independently selected from the group consisting of N, O or S,\n wherein the C 1-6 -alkyl, the C 3-6 -cycloalkyl or the alkylene-bridge is optionally substituted with halogens; \n \u2003W is selected from the group consisting of a monocyclic aryl, monocyclic heteroaryl, monocyclic heterocyclyl and monocyclic cycloalkyl,\n wherein each of these ring systems is optionally substituted with one or more R 3 , and wherein the heteroaryl comprises up to 4 heteroatoms and one or two 5- or 6-membered ring(s); \n \u2003R 3  is independently selected from the group consisting of C 1-6 -alkyl, C 3-8 -cycloalkyl, C 1-6 -alkyl-O\u2014, benzyl, halogen, HO\u2014, NC\u2014, mono- or bicyclic heteroaryl, and 5- or 6-membered monocyclic heterocyclyl containing one heteroatom selected from the group consisting of N, O or S(O) r , wherein the heteroaryl contains up to 4 heteroatoms and one or two 5- or 6-membered ring(s), and r is 0, 1 or 2,\n wherein the C 1-6 -alkyl, C 3-8 -cycloalkyl, C 1-6 -alkyl-O\u2014, benzyl, heteroaryl and the heterocyclyl are optionally substituted with halogens, HO\u2014, acetyl, C 1-6 -alkyl-O\u2014, oxo, R 4 \u2014S(O) 2 \u2014, with R 4  being aryl, C 3-6 -cycloalkyl and/or C 1-6 -alkyl; and \n \u2003Y is selected from the group consisting of a bond and \u2014CH 2 O\u2014.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15526361', '14275879', '15685588', '15157624', '15526360']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8445388040886994
- 35 USC 102 Novelty (BERT): 0.5467004559994972
- Combined Prediction Score: 0.8147549692797792
- Mean Citation Score: 392.438648
- Max Citation Score: 410.2486
- Similarity Product: 345.3216100892186

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test